Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity - PubMed (original) (raw)

. 1989 Jun 1;142(11):3901-8.

Affiliations

PMID: 2523938

Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity

N Uchibayashi et al. J Immunol. 1989.

Abstract

We have undertaken the production of recombinant soluble Fc epsilon receptor II (Fc epsilon RII) as a secretory protein, but not as a cleavage product of membrane-bound receptor. Several plasmid constructs containing soluble receptor sequence were prepared. Only a chimeric gene containing the sequences encoding IL-6 signal peptide and the soluble moiety of Fc epsilon RII could be expressed in Xenopus laevis oocytes and CHO cells, resulting in the secretion of soluble Fc epsilon RII. The recombinant soluble Fc epsilon RII was also produced in the yeast expression system. The NH2-terminal sequence analysis of the chimeric gene product generated by oocytes demonstrated the correct cleavage of IL-6 leader sequence by a signal peptidase. Moreover, most of CHO cell and all of the yeast-derived recombinant molecules were products identical with the native B cell-derived soluble Fc epsilon RII. These recombinant products as well as the natural soluble receptor derived from a human B cell line could bind both human IgE and two different anti-Fc epsilon RII mAb and could competitively inhibit the binding of IgE to Fc epsilon RII-expressing cells. However, the recombinant soluble Fc epsilon RII and highly purified native molecules did not display any B cell growth-promoting activity.

PubMed Disclaimer

Cited by

Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.
Estrov Z, Kurzrock R, Pocsik E, Pathak S, Kantarjian HM, Zipf TF, Harris D, Talpaz M, Aggarwal BB. Estrov Z, et al. J Exp Med. 1993 Mar 1;177(3):763-74. doi: 10.1084/jem.177.3.763. J Exp Med. 1993. PMID: 8382256 Free PMC article.
Defective expression of CD23 and autocrine growth-stimulation in Epstein-Barr virus (EBV)-transformed B cells from patients with Wiskott-Aldrich syndrome (WAS).
Simon HU, Higgins EA, Demetriou M, Datti A, Siminovitch KA, Dennis JW. Simon HU, et al. Clin Exp Immunol. 1993 Jan;91(1):43-9. doi: 10.1111/j.1365-2249.1993.tb03351.x. Clin Exp Immunol. 1993. PMID: 8380367 Free PMC article.
The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice.
Fujiwara H, Kikutani H, Suematsu S, Naka T, Yoshida K, Yoshida K, Tanaka T, Suemura M, Matsumoto N, Kojima S, et al. Fujiwara H, et al. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):6835-9. doi: 10.1073/pnas.91.15.6835. Proc Natl Acad Sci U S A. 1994. PMID: 8041705 Free PMC article.
Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
Tosato G, Tanner J, Jones KD, Revel M, Pike SE. Tosato G, et al. J Virol. 1990 Jun;64(6):3033-41. doi: 10.1128/JVI.64.6.3033-3041.1990. J Virol. 1990. PMID: 2159561 Free PMC article.
Induction of B cell responsiveness to growth factors by Epstein-Barr virus conversion: comparison of endogenous factors and interleukin-1.
Blazar BA, Murphy AM. Blazar BA, et al. Clin Exp Immunol. 1990 Apr;80(1):62-8. doi: 10.1111/j.1365-2249.1990.tb06442.x. Clin Exp Immunol. 1990. PMID: 2157568 Free PMC article.

Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity - PubMed (original) (raw)